Comments

Arcellx Inc Analyst Ratings

ACLXNASDAQ
Trade with Public
Trade with Public
$68.50
-0.15-0.22%
At close: Feb 13, 4:00 PM EST
$68.50
N/A
After Hours: Feb 13, 4:00 PM EST
OverviewNewsEarningsOptionsAnalyst RatingsInsider TradesShort InterestStock Report
Consensus Rating1
Buy
Highest Price Target1
$136.00
Lowest Price Target1
$39.00
Consensus Price Target1
$105.58

Arcellx Analyst Ratings and Price Targets | NASDAQ:ACLX | Benzinga

Arcellx Inc has a consensus price target of $105.58 based on the ratings of 24 analysts. The high is $136 issued by Truist Securities on November 12, 2024. The low is $39 issued by SVB Leerink on March 30, 2023. The 3 most-recent analyst ratings were released by Needham, HC Wainwright & Co., and UBS on February 5, 2026, February 4, 2026, and January 7, 2026, respectively. With an average price target of $106.67 between Needham, HC Wainwright & Co., and UBS, there's an implied 55.72% upside for Arcellx Inc from these most-recent analyst ratings.

Analyst Trends and Forecast

1
1
Oct 25
1
Nov 25
3
Dec 25
1
Jan
2
Feb
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Needham
HC Wainwright & Co.
UBS
Wells Fargo
Canaccord Genuity

1calculated from analyst ratings

Analyst Ratings for Arcellx

Buy NowGet Alert
02/05/2026Buy Now53.28%Needham$105 → $105ReiteratesBuy → BuyGet Alert
02/04/2026Buy Now67.88%HC Wainwright & Co.$115 → $115ReiteratesBuy → BuyGet Alert
01/07/2026Buy Now45.99%UBS → $100AssumesBuy → BuyGet Alert
12/22/2025Buy Now45.99%Wells Fargo → $100Initiates → OverweightGet Alert
12/08/2025Buy Now89.78%Canaccord Genuity$130 → $130MaintainsBuyGet Alert
12/08/2025Buy Now53.28%Needham$105 → $105ReiteratesBuy → BuyGet Alert
11/18/2025Buy Now—Wolfe Research—Initiates → Peer PerformGet Alert
11/03/2025Buy Now89.78%Canaccord Genuity$121 → $130MaintainsBuyGet Alert
10/16/2025Buy Now88.32%Stifel → $129Reinstates → BuyGet Alert
10/09/2025Buy Now28.47%Cantor Fitzgerald → $88Assumes → NeutralGet Alert
07/31/2025Buy Now94.16%Scotiabank$93 → $133MaintainsSector OutperformGet Alert
06/17/2025Buy Now60.58%Citigroup → $110Initiates → BuyGet Alert
06/16/2025Buy Now67.88%HC Wainwright & Co.$115 → $115ReiteratesBuy → BuyGet Alert
05/09/2025Buy Now35.77%Scotiabank$133 → $93MaintainsSector OutperformGet Alert
12/10/2024Buy Now66.42%UBS$106 → $114MaintainsBuyGet Alert
12/10/2024Buy Now67.88%HC Wainwright & Co.$115 → $115ReiteratesBuy → BuyGet Alert
12/10/2024Buy Now53.28%Needham$105 → $105ReiteratesBuy → BuyGet Alert
12/09/2024Buy Now53.28%Needham$105 → $105ReiteratesBuy → BuyGet Alert
11/12/2024Buy Now98.54%Truist Securities$87 → $136MaintainsBuyGet Alert
11/11/2024Buy Now94.16%Scotiabank$82 → $133MaintainsSector OutperformGet Alert
11/08/2024Buy Now67.88%HC Wainwright & Co.$95 → $115MaintainsBuyGet Alert
11/08/2024Buy Now67.88%Piper Sandler$91 → $115MaintainsOverweightGet Alert
11/08/2024Buy Now53.28%Needham$96 → $105MaintainsBuyGet Alert
11/06/2024Buy Now54.74%Morgan Stanley$81 → $106MaintainsOverweightGet Alert
11/06/2024Buy Now45.99%B of A Securities$84 → $100MaintainsBuyGet Alert
11/06/2024Buy Now54.74%Baird$77 → $106MaintainsOutperformGet Alert
11/06/2024Buy Now38.69%HC Wainwright & Co.$80 → $95MaintainsBuyGet Alert
11/06/2024Buy Now40.15%Needham$96 → $96ReiteratesBuy → BuyGet Alert
10/31/2024Buy Now40.15%Needham$96 → $96ReiteratesBuy → BuyGet Alert
10/22/2024Buy Now40.15%Needham$81 → $96MaintainsBuyGet Alert
10/18/2024Buy Now78.1%Stifel$83 → $122MaintainsBuyGet Alert
10/17/2024Buy Now22.63%B of A Securities$80 → $84MaintainsBuyGet Alert
10/17/2024Buy Now67.88%Canaccord Genuity$85 → $115MaintainsBuyGet Alert
09/09/2024Buy Now—Cantor Fitzgerald—Reiterates → OverweightGet Alert
09/03/2024Buy Now—Cantor Fitzgerald—Initiates → OverweightGet Alert
08/09/2024Buy Now18.25%Needham$81 → $81ReiteratesBuy → BuyGet Alert
07/22/2024Buy Now24.09%Canaccord Genuity$85 → $85MaintainsBuyGet Alert
06/18/2024Buy Now27.01%Truist Securities$87 → $87MaintainsBuyGet Alert
05/31/2024Buy Now2.19%Piper Sandler → $70Initiates → OverweightGet Alert
05/15/2024Buy Now21.17%Stifel$82 → $83MaintainsBuyGet Alert
05/14/2024Buy Now24.09%Evercore ISI Group → $85Initiates → OutperformGet Alert
05/13/2024Buy Now16.79%HC Wainwright & Co.$82 → $80MaintainsBuyGet Alert
05/10/2024Buy Now18.25%Needham$81 → $81ReiteratesBuy → BuyGet Alert
05/07/2024Buy Now18.25%Needham$81 → $81ReiteratesBuy → BuyGet Alert
04/11/2024Buy Now18.25%Needham$81 → $81ReiteratesBuy → BuyGet Alert
03/18/2024Buy Now18.25%Needham$72 → $81MaintainsBuyGet Alert
03/14/2024Buy Now19.71%Stifel → $82ReiteratesBuy → BuyGet Alert
03/07/2024Buy Now18.25%Morgan Stanley → $81Initiates → OverweightGet Alert
03/05/2024Buy Now27.01%Truist Securities$57 → $87MaintainsBuyGet Alert
02/29/2024Buy Now19.71%HC Wainwright & Co.$60 → $82MaintainsBuyGet Alert
02/29/2024Buy Now24.09%Canaccord Genuity$66 → $85MaintainsBuyGet Alert
02/29/2024Buy Now6.57%Barclays$62 → $73MaintainsOverweightGet Alert
02/29/2024Buy Now5.11%Needham$71 → $72MaintainsBuyGet Alert
02/29/2024Buy Now12.41%Baird$63 → $77MaintainsOutperformGet Alert
01/04/2024Buy Now3.65%Needham$65 → $71MaintainsBuyGet Alert
12/19/2023Buy Now-3.65%Scotiabank → $66Initiates → Sector OutperformGet Alert
12/12/2023Buy Now-5.11%Needham$65 → $65ReiteratesBuy → BuyGet Alert
12/11/2023Buy Now-5.11%Needham$60 → $65MaintainsBuyGet Alert
11/16/2023Buy Now-3.65%Canaccord Genuity$49 → $66MaintainsBuyGet Alert
11/16/2023Buy Now-9.49%Barclays$49 → $62MaintainsOverweightGet Alert
11/15/2023Buy Now-12.41%HC Wainwright & Co.$50 → $60MaintainsBuyGet Alert
11/15/2023Buy Now-12.41%Needham$51 → $60MaintainsBuyGet Alert
10/30/2023Buy Now—TD Cowen—Initiates → OutperformGet Alert
10/17/2023Buy Now-24.09%UBS → $52Initiates → BuyGet Alert
08/15/2023Buy Now-24.09%Baird$40 → $52MaintainsOutperformGet Alert
08/15/2023Buy Now-24.09%Stifel$54 → $52MaintainsBuyGet Alert
08/15/2023Buy Now-25.55%Needham$51 → $51ReinstatesBuy → BuyGet Alert
08/15/2023Buy Now-27.01%HC Wainwright & Co.$49 → $50MaintainsBuyGet Alert
06/23/2023Buy Now-25.55%Needham → $51ReiteratesBuy → BuyGet Alert
06/21/2023Buy Now-28.47%Canaccord Genuity$49 → $49ReiteratesBuy → BuyGet Alert
06/21/2023Buy Now-28.47%HC Wainwright & Co. → $49ReiteratesBuy → BuyGet Alert
06/20/2023Buy Now—Guggenheim—MaintainsBuyGet Alert
06/20/2023Buy Now-28.47%HC Wainwright & Co. → $49Reiterates → BuyGet Alert
06/20/2023Buy Now-16.79%Truist Securities$60 → $57MaintainsBuyGet Alert
06/20/2023Buy Now-25.55%Needham → $51ReiteratesBuy → BuyGet Alert
05/18/2023Buy Now-12.41%Truist Securities → $60Initiates → BuyGet Alert
05/10/2023Buy Now-27.01%B of A Securities$39 → $50MaintainsBuyGet Alert
05/09/2023Buy Now-28.47%HC Wainwright & Co.$40 → $49MaintainsBuyGet Alert
05/09/2023Buy Now-25.55%Needham$35 → $51MaintainsBuyGet Alert
05/09/2023Buy Now-28.47%Barclays$38 → $49MaintainsOverweightGet Alert
04/26/2023Buy Now-28.47%Canaccord Genuity$40 → $49MaintainsBuyGet Alert
04/24/2023Buy Now-15.33%Guggenheim$45 → $58MaintainsBuyGet Alert
04/19/2023Buy Now-41.61%Canaccord Genuity$34 → $40MaintainsBuyGet Alert
04/14/2023Buy Now-43.07%Baird → $39Initiates → OutperformGet Alert
04/13/2023Buy Now-43.07%Baird → $39Initiates → OutperformGet Alert
03/30/2023Buy Now-48.91%Needham → $35Reiterates → BuyGet Alert
03/30/2023Buy Now-43.07%SVB Leerink$35 → $39MaintainsOutperformGet Alert
03/30/2023Buy Now-41.61%HC Wainwright & Co.$42 → $40MaintainsBuyGet Alert
03/14/2023Buy Now-37.23%Stifel → $43Initiates → BuyGet Alert

FAQ

Q

What is the target price for Arcellx (ACLX) stock?

A

The latest price target for Arcellx (NASDAQ:ACLX) was reported by Needham on February 5, 2026. The analyst firm set a price target for $105.00 expecting ACLX to rise to within 12 months (a possible 53.28% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Arcellx (ACLX)?

A

The latest analyst rating for Arcellx (NASDAQ:ACLX) was provided by Needham, and Arcellx reiterated their buy rating.

Q

When was the last upgrade for Arcellx (ACLX)?

A

There is no last upgrade for Arcellx

Q

When was the last downgrade for Arcellx (ACLX)?

A

There is no last downgrade for Arcellx.

Q

When is the next analyst rating going to be posted or updated for Arcellx (ACLX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Arcellx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Arcellx was filed on February 5, 2026 so you should expect the next rating to be made available sometime around February 5, 2027.

Q

Is the Analyst Rating Arcellx (ACLX) correct?

A

While ratings are subjective and will change, the latest Arcellx (ACLX) rating was a reiterated with a price target of $105.00 to $105.00. The current price Arcellx (ACLX) is trading at is $68.50, which is out of the analyst’s predicted range.

People Also Watch

Immunovant Inc
NASDAQ:IMVT
$25.97
0.85%
Legend Biotech Corp
NASDAQ:LEGN
$17.80
1.25%
Cogent Biosciences Inc
NASDAQ:COGT
$36.75
0.60%
Celcuity Inc
NASDAQ:CELC
$106.92
2.30%
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
$24.71
%
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
$26.00
0.54%
Alkermes PLC
NASDAQ:ALKS
$33.16
%
Xenon Pharmaceuticals Inc
NASDAQ:XENE
$41.48
%

Browse analyst ratings and price targets on all stocks.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved